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BACKGROUND
 Penicillin allergy is one of the most common drug allergies, with
a 10% prevalence in the United States. Only 10% of patients who
self-report a penicillin allergy will react if given penicillin, and
only 1% will experience an Immunoglobulin E (IgE) mediated
reaction if exposed to a cephalosporin or carbapenem3
 Patients who self-report a penicillin allergy are commonly
treated with second line antibiotics such as aztreonam, leading
to unnecessary adverse events, the development of resistant
organisms such as vancomycin-resistant enterococci (VRE), and
an increased prevalence of Clostridioides difficile infections (CDI)
 A “Beta lactam allergy assessment and alternatives to
aztreonam” protocol was implemented at Homestead Hospital
(HH), in order to minimize aztreonam usage while optimizing
antimicrobial therapy
 Despite improvements in the susceptibility rates of
Pseudomonas aeruginosa to aztreonam from 59% in 2016 to
64% in 2017, HH continues to have the lowest susceptibility rate
within the Baptist Health South Florida (BHSF) system, which
might be attributed to the overuse of this antibiotic
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1 (1.5%)
cephalosporins
3rd generation
24 (37%)
cephalosporins
4th generation
20 (31%)
cephalosporin
5th generation
1 (1.5%)
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METHODS
 Retrospective chart review of 154 patients who received
aztreonam from June 1st 2017 to July 31st 2018
 Patients 18 years and older who received aztreonam within the
aforementioned time frame were included in the study
 Each chart was reviewed to determine appropriateness of allergy
documentation, previous beta lactam administration and
tolerance, concomitant antibiotic use, and appropriateness of
aztreonam indication
 The criteria used to assess allergy documentation were severity
and description of event, in accordance to the HH protocol
 The use of aztreonam was considered inappropriate in the
absence of a documented severe penicillin allergy or in patients
for whom beta lactam antibiotics were administered without an
allergic reaction according to current guidelines and HH
protocols
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 To determine whether aztreonam overuse is directly associated
with inappropriate allergy assessment and documentation
 To evaluate the existing penicillin allergy documentation at HH in
order to improve the current “Beta lactam allergy assessment
and alternatives to aztreonam” protocol
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CONCLUSION
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 At HH, 149 (96.75%) patients receiving aztreonam self-reported a
penicillin allergy
 65 (44%) patients received a beta lactam despite self reporting a
penicillin allergy, and 63 (97%) of them tolerated the antibiotic
uneventfully
 84 (56%) patients reporting a penicillin allergy did not receive a
beta lactam antibiotic. Of these, only 19 (23%) reported a severe
penicillin allergic reaction
 Beta lactams administered to patients who self-reported a
penicillin allergy included 3rd generation cephalosporins (37%),
carbapenems (34%), and 4th generation cephalosporin (31%)
 Allergies were inappropriately documented in 77 (50%) patients,
with description of allergy being the most common missing
parameter
 127 (85%) patients received multiple antibiotics. 32 (21%) patients
received one additional antibiotic; 50 (32.5%) received two
antibiotics; 39 (25%) received a combination of three antibiotics,
and 6 (4%) received 4 antibiotics. The most common antimicrobial
agents were vancomycin, levofloxacin and clindamycin
 73 (53%) patients receiving aztreonam were prescribed a second
line agent due to the monobactam’s narrow spectrum of coverage
 Aztreonam was inappropriately used in 133 (87%) patients. The
indication assessment for this antibiotic was not feasible in 8 (5%)
patients due to inappropriate allergy documentation
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In this retrospective chart review it was found that inappropriate
penicillin allergy documentation leads to aztreonam overuse. Due to
the narrow spectrum of coverage of aztreonam, patients required
multiple antibiotics, including vancomycin, levofloxacin, and
clindamycin. Although the impact of this on drug resistance such as
VRE, CDI prevalence, and antibiotic-associated adverse events was
not an endpoint in our study, we acknowledge these are potential
consequences of inappropriately labeling patients with penicillin
allergy.
Further studies addressing the implications of multiple antibiotic use
in patients self reporting a penicillin allergy is recommended.
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